✦ LIBER ✦

Chemoradiotherapy with Weekly Cisplatin 40 mg/m2in 103 Head-and-Neck Cancer Patients

✍ Scribed by Diana Steinmann; Bettina Cerny; Johann Hinrich Karstens; Michael Bremer

Publisher: Springer
Year: 2009
Tongue: German
Weight: 334 KB
Volume: 185
Category: Article
ISSN: 0179-7158
DOI: 10.1007/s00066-009-1989-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly 5-fluorouracil plus cisplatin for

Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer

✍ Young Joo Lee; Chang Geol Lee; Byoung Chul Cho; Gwi Eon Kim; Hye Jin Choi; Eun C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

## Abstract ## Background. In locally advanced head and neck cancer, concurrent chemoradiotherapy (CRT) with combined 5‐fluorouracil (5‐FU) and cisplatin has increased acute toxicities as well as survival. Once‐weekly chemotherapeutic administration schedule may reduce severe toxicities. Thus, we

Dysphagia in Head and Neck Cancer Patien

Dysphagia in Head and Neck Cancer Patients Treated with Chemoradiotherapy

✍ Nele Platteaux; Piet Dirix; Eddy Dejaeger; Sandra Nuyts 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 536 KB

Weekly paclitaxel in patients with recur

Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer

✍ M. Tahara; H. Minami; Y. Hasegawa; K. Tomita; A. Watanabe; K. Nibu; M. Fujii; Y. 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 240 KB

Hyperfractionated accelerated radiothera

Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer

✍ Gabriele K. Beckmann; Florian Hoppe; Leo Pfreundner; Michael P. Flentje 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB 👁 2 views

## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de

Immunologic evaluation of patients with

Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy

✍ Jacob Zighelboim; Fred Dorey; Neil H. Parker; Tom Calcaterra; Paul Ward; John L. 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

Randomized phase 2 study of concomitant

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer

✍ Robert Haddad; Stephen Sonis; Marshall Posner; Lori Wirth; Rosemary Costello; Pa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 1 views

## Abstract ## BACKGROUND: A randomized phase 2 study was performed to investigate the efficacy/toxicity of combining concomitant boost radiation and weekly carboplatin/paclitaxel with or without amifostine in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). ##